Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting

NCT01163604 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT01163604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01163604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting
Lead sponsor
Jinling Hospital, China
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
August 31, 2014
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cvd